AI-Reviewed Research, Clinical Excellence & Evidence-Based Practice— Curated and reviewed by practising aesthetic clinicians

    Journal Hub · Safety & Complications

    Aesthetic Complications Experience

    An academic hub for the recognition, management and prevention of aesthetic complications. Protocols are written for practising clinicians and grounded in PubMed, NICE, BAAPS and BCAM guidance. This hub aggregates HSI Journal articles addressing injectable safety, vascular events, delayed reactions, infection, ophthalmic emergencies and consent standards.

    Abstract

    Background. Tissue necrosis is one of the most feared early complications of aesthetic injection, arising from interruption of vascular supply, external vessel compression, intravascular embolisation of product, or direct tissue trauma. It has been reported across all filler classes, with the glabellar region and nasal tip/alar triangle recognised as the highest-risk anatomical zones.

    Methods. This article is an educational clinical protocol consolidating published evidence rather than a primary study. It reviews recognised incidence figures, cardinal signs and symptoms, high-risk anatomy, and preventive measures, then sets out a stepwise time-critical management algorithm drawn from the existing complications literature and referenced accordingly.

    Results. Reported incidence is approximately 9 per 100,000 with collagen fillers (50% glabellar) and around 1 per 100,000 for dermal fillers overall. Severe pain, prolonged reticulated blanching, dusky discolouration and coolness are identified as cardinal warning signs. The protocol specifies immediate cessation of injection, massage, heat, tapping, and, where hyaluronic acid is implicated, high-dose hyaluronidase flooding across the vascular territory, with adjuncts including nitroglycerin paste, aspirin, antibiotics, wound care and escalation to hyperbaric oxygen or plastic surgery.

    Conclusion. Prompt recognition of impending necrosis and a time-critical, stepwise management pathway — centred on immediate cessation, vasodilatory measures and, where relevant, aggressive hyaluronidase dosing — are essential to limiting tissue loss. The protocol is intended for clinical education and does not replace clinical judgement, local guidelines or emergency escalation.

    Published Protocols & Reviews

    5 articles

    Scope of the Hub

    The Aesthetic Complications Experience covers the core clinical territories below. Each topic is developed as a standalone academic protocol with abstract, evidence review, practical insights and references.

    Vascular Occlusion & Tissue NecrosisLive

    Recognition timelines, hyaluronidase flooding protocols, escalation pathways and post-event review.

    Read protocol

    Vision Loss & Ophthalmic Emergencies

    High-risk zones, retrobulbar approaches, time-critical referral and medico-legal documentation.

    Delayed Onset Nodules & Granulomas

    Inflammatory vs infective differentiation, biofilm hypothesis, intralesional and systemic management.

    Biofilm & Late Infection

    Prevention via dispersion technique, culture-guided antibiotics, surgical drainage thresholds.

    Anaphylaxis & Type I Hypersensitivity

    Adrenaline protocols, anaesthetic and hyaluronidase reactions, resuscitation readiness in clinic.

    Tyndall Effect, Migration & Product-Related AEs

    Plane-specific risk, dissolving protocols, longitudinal follow-up and product accountability.

    Botulinum Toxin Adverse Events

    Ptosis, asymmetry, diffusion errors, antibody resistance and re-treatment intervals.

    Anatomical Danger Zones & Consent Standards

    Zone-by-zone vascular maps, documentation, photography, and informed consent frameworks.

    Editorial Standards

    All complications content is reviewed by the HSI Editorial Board against current literature in PubMed, NICE, JAMA Dermatology, Aesthetic Surgery Journal and JCAD. Protocols are educational and do not substitute clinical judgement, local guidelines or emergency services. Practitioners must hold appropriate indemnity and competency for procedures referenced.